Futura Medical (LON:FUM) Shares Up 10.9% – Time to Buy?

Futura Medical plc (LON:FUM)’s share price traded up 10.9% during mid-day trading on Thursday . The stock traded as high as GBX 0.52 and last traded at GBX 0.51. Approximately 5,393,217 shares traded hands during trading, a decline of 37% from the average session volume of 8,544,223 shares. The stock had previously closed at GBX 0.46.

Futura Medical Trading Up 10.9%

The business has a 50-day moving average of GBX 0.74 and a 200 day moving average of GBX 1.05. The firm has a market capitalization of £2.96 million, a PE ratio of -0.18 and a beta of 0.02.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The firm had revenue of GBX 170 million for the quarter. On average, sell-side analysts expect that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.